Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study.
Chaumeil MM, Valette J, Baligand C, Brouillet E, Hantraye P, Bloch G, Gaura V, Rialland A, Krystkowiak P, Verny C, Damier P, Remy P, Bachoud-Levi AC, Carlier P, Lebon V. Chaumeil MM, et al. Among authors: valette j. J Cereb Blood Flow Metab. 2012 May;32(5):771-9. doi: 10.1038/jcbfm.2012.15. Epub 2012 Feb 29. J Cereb Blood Flow Metab. 2012. PMID: 22373643 Free PMC article.
The neuroprotective agent CNTF decreases neuronal metabolites in the rat striatum: an in vivo multimodal magnetic resonance imaging study.
Carrillo-de Sauvage MA, Flament J, Bramoulle Y, Ben Haim L, Guillermier M, Berniard A, Aurégan G, Houitte D, Brouillet E, Bonvento G, Hantraye P, Valette J, Escartin C. Carrillo-de Sauvage MA, et al. Among authors: valette j. J Cereb Blood Flow Metab. 2015 Jun;35(6):917-21. doi: 10.1038/jcbfm.2015.48. Epub 2015 Apr 1. J Cereb Blood Flow Metab. 2015. PMID: 25833344 Free PMC article.
Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.
Audrain M, Fol R, Dutar P, Potier B, Billard JM, Flament J, Alves S, Burlot MA, Dufayet-Chaffaud G, Bemelmans AP, Valette J, Hantraye P, Déglon N, Cartier N, Braudeau J. Audrain M, et al. Among authors: valette j. Mol Neurodegener. 2016 Jan 12;11:5. doi: 10.1186/s13024-016-0070-y. Mol Neurodegener. 2016. PMID: 26759118 Free PMC article.
Energy defects in Huntington's disease: Why "in vivo" evidence matters.
Liot G, Valette J, Pépin J, Flament J, Brouillet E. Liot G, et al. Among authors: valette j. Biochem Biophys Res Commun. 2017 Feb 19;483(4):1084-1095. doi: 10.1016/j.bbrc.2016.09.065. Epub 2016 Sep 14. Biochem Biophys Res Commun. 2017. PMID: 27639641 Review.
The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin.
Galvan L, Francelle L, Gaillard MC, de Longprez L, Carrillo-de Sauvage MA, Liot G, Cambon K, Stimmer L, Luccantoni S, Flament J, Valette J, de Chaldée M, Auregan G, Guillermier M, Joséphine C, Petit F, Jan C, Jarrige M, Dufour N, Bonvento G, Humbert S, Saudou F, Hantraye P, Merienne K, Bemelmans AP, Perrier AL, Déglon N, Brouillet E. Galvan L, et al. Among authors: valette j. Brain. 2018 May 1;141(5):1434-1454. doi: 10.1093/brain/awy057. Brain. 2018. PMID: 29534157 Free PMC article.
150 results